Clinical Trial Update: Visual Performance After RESTOR Implantation [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing study assessing visual performance after RESTOR multifocal intraocular lens implantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Presbyopia

Drugs mentioned

• ReSTOR Intraocular Lens (Intraocular lens, aspheric, multifocal)

Snippet

Sponsor: Hospital Oftalmologico de Brasilia | Conditions: Refractive Assessment | Phase 4 | Status: COMPLETED